FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• HUMULIN 70/30 (INSULIN HUMAN)

Snippet

SUPPL AP for HUMULIN 70/30 (INSULIN HUMAN)